A Phase 1b/2 Study To Evaluate Safety And Clinical Activity Of Avelumab In Combination With Binimetinib With Or Without Talazoparib In Patients With Locally Advanced Or Metastatic Ras-mutant Solid Tumors
Phase of Trial: Phase I/II
Latest Information Update: 13 Dec 2018
At a glance
- Drugs Avelumab (Primary) ; Binimetinib (Primary) ; Talazoparib (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer; Pancreatic cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Pfizer
- 28 Aug 2018 Status changed from not yet recruiting to recruiting.
- 20 Aug 2018 Status changed from planning to not yet recruiting.
- 22 Dec 2017 New trial record